U Hess

High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

Monique Terwijn, Wim L.J. van Putten, Angèle Kelder et al. · Journal of Clinical Oncology · 2013 · 444 citations · Full text

Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia

Sébastien Maury, Sylvie Chevret, Xavier Thomas et al. · New England Journal of Medicine · 2016 · 340 citations · Full text

Long-Term Follow-Up of Patients With Follicular Lymphoma Receiving Single-Agent Rituximab at Two Different Schedules in Trial SAKK 35/98

Giovanni Martinelli, Shu-Fang Hsu Schmitz, Urs Utiger et al. · Journal of Clinical Oncology · 2010 · 240 citations · Full text

Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial

Stéphane de Botton, Sylvie Chevret, Miguel Á. Sanz et al. · British Journal of Haematology · 2000 · 145 citations

Hematological Malignancy, Medicine, European Trial +15

Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement

Pierre Chopard, Janine Dörffler-Melly, U Hess et al. · Journal of Internal Medicine · 2005 · 91 citations · Full text